URMC Heart Researchers Launch $27M ICD Study
The study may decrease the use of implantable cardioverter defibrillators (ICD), as advances in medical therapies have improved outcomes for patients with heart failure.
The study may decrease the use of implantable cardioverter defibrillators (ICD), as advances in medical therapies have improved outcomes for patients with heart failure.
AbstractAims. Heart failure (HF) with preserved ejection fraction disproportionately affects women. There are no validated sex-specific tools for HF diagno
Cardiologist Dr. Fahmi Farah’s weekly segment live every Wednesday at 2:30pm CT on SiriusXM’s Road Dog Trucking Channel 146.Contact Dr. Farah:https://bentley…
Human life reveals God’s purpose and shows God’s glory—so we must always protect the sanctity of life. No matter who you are or where you’re…
Empower healthcare professionals with the latest insights on cardiovascular health, tackling treatment disparities and optimizing prevention strategies. Stay abreast of evolving clinical evidence and address…
Scientists have recently discovered thousands of active RNA molecules that can control the human body
The 5th Annual TechAwards were our biggest and best yet. Hosted by the fantastic UK comedian Zoe Lyons.
We offer support to help people live well with heart failure. Sunday, 08 September 2024 Gateshead, Newcastle Half marathon Charity-Funded Sign up now and run…
Initiated by Abbott/Thoratec and deemed Class I by the FDA, the recall is in response to reports of 70 injuries and two deaths.
IgG4-related disease (IgG4-RD) is a systemic immune-mediated disease that can involve nearly any organ. IgG4-RD can affect the kidney in different disease patterns, collectively referred…